| Literature DB >> 27009151 |
William W Motley1, Paulius Palaima2, Sabrina W Yum3, Michael A Gonzalez4, Feifei Tao4, Julia V Wanschitz5, Alleene V Strickland4, Wolfgang N Löscher5, Els De Vriendt2, Stefan Koppi6, Livija Medne7, Andreas R Janecke8, Albena Jordanova2, Stephan Zuchner4, Steven S Scherer9.
Abstract
We performed whole exome sequencing on a patient with Charcot-Marie-Tooth disease type 1 and identified a de novo mutation in PMP2, the gene that encodes the myelin P2 protein. This mutation (p.Ile52Thr) was passed from the proband to his one affected son, and segregates with clinical and electrophysiological evidence of demyelinating neuropathy. We then screened a cohort of 136 European probands with uncharacterized genetic cause of Charcot-Marie-Tooth disease and identified another family with Charcot-Marie-Tooth disease type 1 that has a mutation affecting an adjacent amino acid (p.Thr51Pro), which segregates with disease. Our genetic and clinical findings in these kindred demonstrate that dominant PMP2 mutations cause Charcot-Marie-Tooth disease type 1.Entities:
Keywords: CMT; Charcot-Marie-Tooth disease; PMP2; myelin P2 protein; peripheral neuropathy
Mesh:
Substances:
Year: 2016 PMID: 27009151 PMCID: PMC5022672 DOI: 10.1093/brain/aww055
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501